公开(公告)号：DE60307551D1

公开(公告)日：2006-09-28

申请号：DE60307551

申请日：2003-06-16

Applicant: OLYMPUS CORP

Inventor： SHIGA NAOHITO ,  OBI KUNIHISA ,  GOTO ATSUSHI ,  TAKEYAMA TETSUHIDE ,  SHIRAI MICHIO

IPC: G02B1/04 ,  C08K3/00 ,  C08K3/16 ,  C08L27/12 ,  C08L83/04 ,  G02B1/00 ,  G02B3/00

公开(公告)号：DE60041287D1

公开(公告)日：2009-02-12

申请号：DE60041287

申请日：2000-03-13

Applicant: OLYMPUS CORP

Inventor： TOGINO TAKAYOSHI ,  TAKEYAMA TETSUHIDE

IPC: G02B27/01 ,  G02B5/30 ,  G02B17/08 ,  G02B25/00 ,  G02B27/00

Abstract: A compact, bright and high-performance viewing optical system and an image display apparatus using the same. The viewing optical system uses an ocular optical system, which is formed from a decentered prism, and a reflection type image display device (203) forming a first image to be viewed by an observer. The image display device (203) has a light source (204) and an illuminating light guide prism (206) for guiding a light beam from the light source so that the light beam is applied to the display surface from the front side thereof. The ocular optical system includes a prism having an entrance surface (213) through which a light beam reflected from the display surface enters the prism after passing through the illuminating light guide prism (206). The prism (210) further has a reflecting surface (212) and an exit surface (211) through which the light beam exits from the prism. The reflecting surface (212) is decentered with respect to the optical axis and has a rotationally asymmetric curved surface configuration that corrects decentration aberrations due to the decentration of the reflecting surface (212) and gives a power to the light beam. The viewing optical system further includes a see-through optical element (220) so as to lead a second image, such as from the outside world, to the observer's eye. The curved reflecting surface (212) of the prism (210) has a transmitting action to allow a light beam from the second image to enter the ocular optical system after passing through the see-through optical element. The combined optical power and the combined angular magnification of the ocular optical system and the see-through optical element are arranged so that the outside world or the like can be seen in the same way as with the naked eye.

公开(公告)号：DE60307551T2

公开(公告)日：2007-09-13

申请号：DE60307551

申请日：2003-06-16

Applicant: OLYMPUS CORP

Inventor： SHIGA NAOHITO ,  OBI KUNIHISA ,  GOTO ATSUSHI ,  TAKEYAMA TETSUHIDE ,  SHIRAI MICHIO

IPC: G02B1/04 ,  C08K3/00 ,  C08K3/16 ,  C08L27/12 ,  C08L83/04 ,  G02B1/00 ,  G02B3/00

公开(公告)号：EP2992809A4

公开(公告)日：2017-01-11

申请号：EP14823647

申请日：2014-03-31

Applicant: OLYMPUS CORP

Inventor： IMAIZUMI KATSUICHI ,  TAKEYAMA TETSUHIDE ,  SAKAI YUJI ,  OKITA YOSHINARI

IPC: A61B1/04 ,  A61B5/06 ,  G02B23/24

CPC classification number: A61B1/00055 ,  A61B1/00009 ,  A61B1/00045 ,  A61B1/00154 ,  A61B1/04 ,  A61B5/065

公开(公告)号：EP3173791A4

公开(公告)日：2017-12-13

申请号：EP15824079

申请日：2015-03-16

Applicant: OLYMPUS CORP

Inventor： SANUKI HIROMI ,  NAKATA MARI ,  TAKEYAMA TETSUHIDE

IPC: G01N33/68 ,  G01N33/48

CPC classification number: G01N33/68 ,  G01N33/48

Abstract: A method of determining pancreatic disease of the present invention is a method of determining whether an IPMN patient has pancreatic disease, the method including: a first step of measuring a concentration of S100P in duodenal juice of the IPMN patient; and a second step of determining at least one of IPMN malignancy and the presence of pancreatic cancer in the IPMN patient based on determination of whether the concentration of the S100P is equal to or greater than a predetermined cutoff value.

公开(公告)号：EP3018480A4

公开(公告)日：2017-02-08

申请号：EP14819349

申请日：2014-04-15

Applicant: OLYMPUS CORP

Inventor： TAKEICHI RIE ,  MORIYA NAO ,  SANUKI HIROMI ,  NAKATA MARI ,  KIYOHARA MASANOBU ,  TAKEYAMA TETSUHIDE ,  NAGAOKA TOMONORI

IPC: G01N33/72 ,  A61B5/00 ,  A61B5/103 ,  A61B10/00 ,  G01J3/42 ,  G01J3/46 ,  G01N21/29 ,  G01N21/31 ,  G01N33/48 ,  G01N33/50 ,  G01N33/52 ,  G01N33/574 ,  G01N33/68

CPC classification number: G01N33/57438 ,  A61B5/1032 ,  A61B5/4283 ,  A61B2010/0061 ,  G01N21/29 ,  G01N21/293 ,  G01N21/31 ,  G01N33/48 ,  G01N33/6872 ,  G01N2333/70503 ,  G01N2800/067

Abstract: Provided are a method for exclusively selecting a duodenal fluid sample having a high possibility of containing pancreatic fluid and favorable sample suitability for subjecting to detection of a pancreatic disease marker by evaluating the quality of the sample prior to detecting the pancreatic disease marker, and a method for detecting a pancreatic disease marker using a duodenal fluid sample selected according to that method. Namely, a method is provided for selecting a duodenal fluid sample for detecting a pancreatic disease marker, comprising: (a1) a step of comparing the color depth of a duodenal fluid sample with a prescribed standard color, and (b1) a step of determining that a duodenal fluid sample is subjected to a test for a pancreatic disease marker if the color depth thereof is equal to or higher than the standard color, but that the duodenal fluid sample is not subjected to a test for a pancreatic disease marker if the color depth thereof is lower than the standard color.

公开(公告)号：EP1494053A4

公开(公告)日：2011-03-16

申请号：EP03715536

申请日：2003-03-27

Applicant: OLYMPUS CORP

Inventor： MIHARA SHINICHI ,  KONISHI HIROKAZU ,  WATANABE MASAHITO ,  ISHII ATSUJIRO ,  TAKEYAMA TETSUHIDE ,  IMAMURA AYAMI ,  HANZAWA TOYOHARU

IPC: G02B13/18 ,  G02B15/167 ,  G02B15/177 ,  G02B15/20

CPC classification number: G02B15/177 ,  G02B5/04